BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28629519)

  • 1. Erythropoietin: Endogenous Protection of Ischemic Brain.
    Mallet RT; Ryou MG
    Vitam Horm; 2017; 105():197-232. PubMed ID: 28629519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin: powerful protection of ischemic and post-ischemic brain.
    Nguyen AQ; Cherry BH; Scott GF; Ryou MG; Mallet RT
    Exp Biol Med (Maywood); 2014 Nov; 239(11):1461-75. PubMed ID: 24595981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting neurons.
    Ferriero DM
    Epilepsia; 2005; 46 Suppl 7():45-51. PubMed ID: 16201995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery to the ischemic brain.
    Thompson BJ; Ronaldson PT
    Adv Pharmacol; 2014; 71():165-202. PubMed ID: 25307217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats.
    Bahcekapili N; Uzüm G; Gökkusu C; Kuru A; Ziylan YZ
    Life Sci; 2007 Mar; 80(14):1245-51. PubMed ID: 17300815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovascular Unit Protection From Cerebral Ischemia-Reperfusion Injury by Radical-Containing Nanoparticles in Mice.
    Hosoo H; Marushima A; Nagasaki Y; Hirayama A; Ito H; Puentes S; Mujagic A; Tsurushima H; Tsuruta W; Suzuki K; Matsui H; Matsumaru Y; Yamamoto T; Matsumura A
    Stroke; 2017 Aug; 48(8):2238-2247. PubMed ID: 28655813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
    Thériault P; Le Béhot A; ElAli A; Rivest S
    Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.
    Liu R; Suzuki A; Guo Z; Mizuno Y; Urabe T
    J Neurochem; 2006 Feb; 96(4):1101-10. PubMed ID: 16417583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic hypothermia for global and focal ischemic brain injury--a cool way to improve neurologic outcomes.
    Hoesch RE; Geocadin RG
    Neurologist; 2007 Nov; 13(6):331-42. PubMed ID: 18090711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebral ischemia-hypoxia and biophysical mechanisms of neurodegeneration and neuroprotection effects].
    Mahura IS
    Fiziol Zh (1994); 2003; 49(2):7-12. PubMed ID: 12945108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Featured Article: Pyruvate preserves antiglycation defenses in porcine brain after cardiac arrest.
    Scott GF; Nguyen AQ; Cherry BH; Hollrah RA; Salinas I; Williams AG; Ryou MG; Mallet RT
    Exp Biol Med (Maywood); 2017 May; 242(10):1095-1103. PubMed ID: 28361585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of aromatic resuscitation drugs on blood brain barrier in cerebral ischemia-reperfusion injury model rats].
    Ni C; Zeng N; Xu F; Gou L; Liu J; Wang J; Xia H
    Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(18):2562-6. PubMed ID: 22256767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.
    Kamada H; Yu F; Nito C; Chan PH
    Stroke; 2007 Mar; 38(3):1044-9. PubMed ID: 17272778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion.
    Wang R; Wu X; Liang J; Qi Z; Liu X; Min L; Ji X; Luo Y; Zhao H
    Int J Neurosci; 2015; 125(9):693-702. PubMed ID: 25226558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of cerebral ischemia-reperfusion injury based on liposomal drug delivery system with asialo-erythropoietin.
    Ishii T; Asai T; Oyama D; Fukuta T; Yasuda N; Shimizu K; Minamino T; Oku N
    J Control Release; 2012 May; 160(1):81-7. PubMed ID: 22342472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin can scavenge peroxynitrite and ameliorate endogenous peroxynitrite-mediated neurotoxicity in cerebral ischemia-reperfusion injury.
    Xu M; Chen X; Gu Y; Peng T; Yang D; Chang RC; So KF; Liu K; Shen J
    J Ethnopharmacol; 2013 Oct; 150(1):116-24. PubMed ID: 23973788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats.
    Wu J; Chen Y; Yu S; Li L; Zhao X; Li Q; Zhao J; Zhao Y
    Brain Res Bull; 2017 Jun; 132():99-108. PubMed ID: 28552673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of erythtropoietin in cerebral diseases.
    Cotena S; Piazza O; Tufano R
    Panminerva Med; 2008 Jun; 50(2):185-92. PubMed ID: 18607342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.